Liposomal GM1 for the treatment of neuro degenerative diseases e.g. Parkinson’s disease.
Alzheimer’s disease
Has the potential to treat multiple rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses, and Niemann-Pick disease type C (NPC).
Neuroinflammation